Treatment efficacy in rheumatoid arthritis patients depended on their somatotypogical status
Summary. The study assessed the efficiency and safety of standard treatment of patients with rheumatoid arthritis, depending upon their somatotypogical status. Analysis of the effective treatment depending on patients’ somatotypes with rheumatoid arthritis showed that the endomorphy somatotype is a predictor of patients resistance to standard therapy. For 3 months of treatment among endomorph responders at the ACR20 were 40% and ACR50 — 13%, while among patients with balanced somatotypes these were respectively 1.25 and 1.9 times more.
No Comments » Add your